Skip to content

The prospective clinical study of a new exosomal miRNAs biomarkers in early warning of gallbladder cancer and screening of the high-risk population

The prospective clinical study of a new exosomal miRNAs biomarkers in early warning of gallbladder cancer and screening of the high-risk population

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036653
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-08
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder cancer

Interventions

High exosomal miRNAs score group:N/A
Low exosomal miRNAs score group:N/A

Sponsors

The Third Affiliated Hospital of PLA Navy Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Over 18 years old, less than 70 years old; 2. Gender: male or female; 3. Coagulation function index was in normal range; 4. The subjects (or their legal representatives) have signed the informed consent form; 5. Patients with clinically confirmed cholecystolithiasis, cystic adenomatous polyp, bile duct cyst, abnormal confluence of bile duct and pancreatic duct, or chronic gallbladder inflammation such as xanthogranulomatous cholecystitis, any one of them.

Exclusion criteria

Exclusion criteria: 1. The patient or his/her authorized person is not willing to sign the written informed consent or to comply with the study protocol; 2. Those who have no decision-making ability or mental illness patients; 3. Patients with serious heart, brain, liver and kidney diseases; 4. Patients with severe vascular and hematological diseases; 5. Unable to visit the hospital regularly; 6. Pregnant and lactating women; 7. Patients receiving other trial drugs or in other diagnostic clinical trials at the same time.

Design outcomes

Primary

MeasureTime frame
Incidence rate;

Secondary

MeasureTime frame
Sensibility;Specificity;Overall survival;Disease free survival;

Countries

China

Contacts

Public ContactZhang Baohua

The Third Affiliated Hospital of PLA Navy Medical University

zhbh_1@163.com+86 13611690000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026